Analyst Expectations For Staar Surgical's Future
Analyst Expectations For Staar Surgical's Future
分析師對staar surgical未來的預期
5 analysts have shared their evaluations of Staar Surgical (NASDAQ:STAA) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近的三個月裏，有5位分析師對Staar Surgical（NASDAQ: STAA）進行了評估，並做出了看好和看淡的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $44.2, a high estimate of $53.00, and a low estimate of $37.00. This current average represents a 6.46% decrease from the previous average price target of $47.25.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A clear picture of Staar Surgical's perception among financial...
積極的營業收入趨勢：...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。